NCT03602586 2024-07-26Testing Whether the Combination of Two Immunotherapy Drugs Have Activity in Recurrent or Persistent Clear Cell Ovarian CancerNational Cancer Institute (NCI)Phase 2 Completed14 enrolled 12 charts